Product Information

TETRABENAZINE 12.5 MG TABLET is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.8043 per EA under NDC 70436010109. Its NADAC has been published 170 times since Feb 22, 2023.

The Low Outlier badge above means this manufacturer's average price in the tetrabenazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TETRABENAZINE 12.5 MG TABLET

tetrabenazine
$0.8043per EA
Low Outlier

Strength

12.5 mg/1

NDC

70436010109

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

5/20/2026

Active Ingredients

TETRABENAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213316

On Market Since

3/2/2020

Pharmacological Classes

Vesicular Monoamine Transporter 2 Inhibitor
Vesicular Monoamine Transporter 2 Inhibitors

Price Statistics

The NADAC for TETRABENAZINE 12.5 MG TABLET has been published 170 times since Feb 22, 2023, and over the history we have for it it has declined 69.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8043 per EA
All-time high$3.2465 (Dec 13, 2023)
All-time low$0.7645 (Sep 17, 2025)
52-week high$1.1399
52-week low$0.7645
Median price$1.5454
Average price$1.7473
Largest weekly change-63.3% (Dec 20, 2023)
Weeks tracked170
Tracking sinceFeb 22, 2023

Price History

1W

0.0%

1M

0.0%

3M

+2.4%

6M

+0.5%

1Y

-29.4%

3Y

-75.2%

5Y

N/A

All

-69.0%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TETRABENAZINE 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TETRABENAZINE 12.5 MG TABLET, manufactured by Slate Run Pharmaceuticals LLC, is $0.8043 per EA (NDC 70436010109), effective May 20, 2026.

How has the price of TETRABENAZINE 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TETRABENAZINE 12.5 MG TABLET has declined 69.0%. It has been tracked across 170 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for TETRABENAZINE 12.5 MG TABLET?

Since Feb 22, 2023, the NADAC for TETRABENAZINE 12.5 MG TABLET has ranged from a low of $0.7645 (Sep 17, 2025) to a high of $3.2465 (Dec 13, 2023), with a median of $1.5454 per EA.

Are there cheaper alternatives to TETRABENAZINE 12.5 MG TABLET?

Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TETRABENAZINE 12.5 MG TABLET, is $0.7645 per EA — about 5% below TETRABENAZINE 12.5 MG TABLET.

Who manufactures TETRABENAZINE 12.5 MG TABLET?

TETRABENAZINE 12.5 MG TABLET (NDC 70436010109) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.